Title:
Communicable diseases are not communicable

dc.contributor.author Kostoff, Ronald N.
dc.contributor.author Briggs, Michael B.
dc.contributor.author Kanduc, Darja
dc.contributor.author Porter, Alan L.
dc.contributor.author Buchtel, Henry A.
dc.contributor.corporatename Georgia Institute of Technology. School of Public Policy en_US
dc.contributor.corporatename University of Bari, Italy. Department of Biosciences en_US
dc.contributor.corporatename University of Michigan. Department of Psychiatry en_US
dc.date.accessioned 2020-10-28T16:09:45Z
dc.date.available 2020-10-28T16:09:45Z
dc.date.issued 2020-10
dc.description.abstract Communicable disease is a misnomer. The disease is not communicable; the microbe mainly associated with the disease is communicable. Whether the recipient of the microbe develops the disease depends on the health of the recipient’s immune system. Our model of COVID-19 development starts with real-life exposures to multiple toxic stressors degrading the immune system. This is followed by the SARS-CoV-2 virus exploiting the degraded immune system to trigger a chain of events ultimately leading to COVID-19. To prevent or treat infectious disease, the health of the immune system must be maintained or improved. One major component of maintaining and improving immune system health is removal of those factors that contribute to immune system degradation. A previous monograph identified many factors that contribute to immune system degradation (Contributing Factors (CFs)). It was hypothesized that many of these CFs to immune system degradation were identical to those that past studies have shown were CFs to chronic diseases. To test this hypothesis, a proof-of-principle demonstration was performed to identify the commonality between CFs to immune system degradation and CFs to Parkinson’s Disease (PD). A very streamlined approach was used, and approximately 500 CFs were found in common between the two diseases. Since COVID-19 (and other infectious diseases) results from immune system degradation in our model, this means COVID-19 and PD are enabled by many of the same toxic exposures and toxic behaviors. Thus, many of the measures required to strategically treat and prevent infectious diseases are similar to those required to strategically treat and prevent chronic diseases. This is a major paradigm shift for orthodox Western medicine, but is required to achieve major advances in global population health. en_US
dc.identifier.uri http://hdl.handle.net/1853/63805
dc.language.iso en_US en_US
dc.publisher Georgia Institute of Technology en_US
dc.rights Attribution 3.0 United States *
dc.rights.uri http://creativecommons.org/licenses/by/3.0/us/ *
dc.subject Covid-19 en_US
dc.subject Coronavirus en_US
dc.subject Pandemic en_US
dc.subject SARS-CoV-2 en_US
dc.subject Severe Acute Respiratory Syndrome en_US
dc.subject Parkinson's disease en_US
dc.subject Immune system degradation en_US
dc.subject TechMining en_US
dc.subject Contributing Factors en_US
dc.title Communicable diseases are not communicable en_US
dc.type Text
dc.type.genre Pre-print
dspace.entity.type Publication
local.contributor.author Porter, Alan L.
local.contributor.corporatename School of Public Policy
local.contributor.corporatename Ivan Allen College of Liberal Arts
relation.isAuthorOfPublication c1d2e529-66b8-4041-aa69-0d51fd33b7b9
relation.isOrgUnitOfPublication a3789037-aec2-41bb-9888-1a95104b7f8c
relation.isOrgUnitOfPublication b1049ff1-5166-442c-9e14-ad804b064e38
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
COMMUNICABLE_VS_NON_COMMUNICABLE_DISEASES_FINAL_10_28_2020.pdf
Size:
300.17 KB
Format:
Adobe Portable Document Format
Description:
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
3.13 KB
Format:
Item-specific license agreed upon to submission
Description: